Cargando…

Hepatobiliary contrast agents: differential diagnosis of focal hepatic lesions, pitfalls and other indications

The characterization of focal liver lesions is very important. Magnetic resonance imaging is considered the best imaging method for evaluating such lesions, but does not allow for the diagnosis in all cases. The use of hepatobiliary contrast agents increases the diagnostic accuracy of magnetic reson...

Descripción completa

Detalles Bibliográficos
Autores principales:	Francisco, Flávia Angélica Ferreira, de Araújo, Antonio Luis Eiras, Oliveira Neto, Jaime Araújo, Parente, Daniella Braz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Colégio Brasileiro de Radiologia e Diagnóstico por Imagem 2014
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4341386/ https://www.ncbi.nlm.nih.gov/pubmed/25741105 http://dx.doi.org/10.1590/0100-3984.2013.1867

Ejemplares similares

Fat-containing liver lesions: a pictorial review
por: Parente, Daniella Braz, et al.
Publicado: (2018)

Additional value of a dynamic contrast-enhanced study for detection of a small neuroendocrine tumor of the rectum on magnetic resonance imaging
por: Lima, Leandro Lucas, et al.
Publicado: (2019)

Hepatobiliary phases in magnetic resonance imaging using liver-specific contrast for focal lesions in clinical practice
por: Fernandes, Daniel Alvarenga, et al.
Publicado: (2022)

Hepatobiliary-Specific Contrast Agent in Biliary Leak
por: Médart, Laurent, et al.
Publicado: (2018)

MRI with hepatobiliary contrast
por: Jhaveri, Kartik S
Publicado: (2015)

Radiological findings in the liver of a patient with Rendu-Osler-Weber syndrome
por: Rodrigues, Rafael Amaral, et al.
Publicado: (2019)

Focal nodular hyperplasia: hepatobiliary enhancement patterns on gadoxetic-acid contrast-enhanced MRI
por: van Kessel, C. S., et al.
Publicado: (2012)

Hepatobiliary-specific magnetic resonance contrast agents: role in biliary trauma
por: Di Serafino, Marco, et al.
Publicado: (2023)

Liver Imaging and Hepatobiliary Contrast Media
por: Pastor, Catherine M., et al.
Publicado: (2018)

The role of contrast-enhanced ultrasound in the evaluation of hepatobiliary lesions and its correlation with pathological findings
por: Kumar, Krishan, et al.
Publicado: (2022)

Quantification of contrast agent uptake in the hepatobiliary phase helps to differentiate hepatocellular carcinoma grade
por: Haimerl, Michael, et al.
Publicado: (2021)

Intraindividual Comparison of Hepatocellular Carcinoma Washout between MRIs with Hepatobiliary and Extracellular Contrast Agents
por: Kim, Yeun-Yoon, et al.
Publicado: (2021)

The role of MRI using liver-specific contrast agent in the assessment of focal liver lesion
por: D'Ippolito, Giuseppe
Publicado: (2014)

Complete spontaneous regression of giant focal nodular hyperplasia of the liver: Magnetic resonance imaging evaluation with hepatobiliary contrast media
por: Mamone, Giuseppe, et al.
Publicado: (2016)

The evaluation of contrast-enhancing brain lesions: pitfalls in current practice.
por: Piszczor, M., et al.
Publicado: (1985)

Focal Hepatic Lesions: Contrast-Enhancement Patterns at Pulse-Inversion Harmonic US using a Microbubble Contrast Agent
por: Kim, Eun-A, et al.
Publicado: (2003)

Hepatobiliary MR contrast agents are useful to diagnose hepatocellular carcinoma in patients with Budd-Chiari syndrome
por: Van Wettere, Morgane, et al.
Publicado: (2020)

Epidural cavernous hemangioma of the spine: magnetic resonance imaging findings
por: Martins, Marcelo Mantiolhe, et al.
Publicado: (2015)

Added value of Gd-EOB-DTPA-enhanced Hepatobiliary phase MR imaging in evaluation of focal solid hepatic lesions
por: Haimerl, Michael, et al.
Publicado: (2013)

Contrast-enhanced ultrasonography features of hepatobiliary neoplasms in cats
por: Banzato, Tommaso, et al.
Publicado: (2020)

MDCT in the preoperative staging of gastric adenocarcinoma
por: Parente, Daniella Braz
Publicado: (2015)

Imaging methods in the assessment of nonalcoholic fatty liver disease
por: Parente, Daniella Braz
Publicado: (2020)

The Role of US Contrast Agents in US-Guided Biopsy of Focal Liver Lesions: A Pictorial Review
por: Lorentzen, Torben, et al.
Publicado: (2019)

Focal Pancreatic Lesions: Role of Contrast-Enhanced Ultrasonography
por: Bartolotta, Tommaso Vincenzo, et al.
Publicado: (2021)

Is MR Spectroscopy Really the Best MR-Based Method for the Evaluation of Fatty Liver in Diabetic Patients in Clinical Practice?
por: Parente, Daniella Braz, et al.
Publicado: (2014)

The use of contrast-enhanced ultrasound in the characterisation of focal liver lesions
por: Soye, JA, et al.
Publicado: (2007)

Contrast-enhanced ultrasonography for the evaluation of malignant focal liver lesions
por: Chammas, Maria Cristina, et al.
Publicado: (2022)

Focal liver lesions in cirrhosis: Role of contrast-enhanced ultrasonography
por: Bartolotta, Tommaso Vincenzo, et al.
Publicado: (2022)

Contrast-enhanced ultrasound features of focal pancreatic lesions in cats
por: Burti, Silvia, et al.
Publicado: (2022)

MRI characterization of focal liver lesions in non-cirrhotic patients: assessment of added value of gadoxetic acid-enhanced hepatobiliary phase imaging
por: Moosavi, Bardia, et al.
Publicado: (2020)

Evaluation of Hemodynamics in Focal Steatosis and Focal Spared Lesion of the Liver Using Contrast-Enhanced Ultrasonography with Sonazoid
por: Shiozawa, Kazue, et al.
Publicado: (2014)

Value of Contrast-Enhanced Ultrasound in the Differential Diagnosis of Focal Splenic Lesions
por: Yang, Rui, et al.
Publicado: (2021)

Contrast‐enhanced ultrasound is useful for the evaluation of focal liver lesions in children
por: Torres, Alvaro, et al.
Publicado: (2021)

Hepatobiliary
Publicado: (2013)

Predicting Therapeutic Efficacy of Vascular Disrupting Agent CA4P in Rats with Liver Tumors by Hepatobiliary Contrast Agent Mn-DPDP-Enhanced MRI
por: Liu, Yewei, et al.
Publicado: (2019)

Hepatobiliary strongyloidiasis presenting as an ampullary lesion on esophagogastroduodenoscopy/endoscopic ultrasound
por: Ofori, Emmanuel, et al.
Publicado: (2018)

Comparison of LI-RADS v.2017 and ESGAR Guidelines Imaging Criteria in HCC Diagnosis Using MRI with Hepatobiliary Contrast Agents
por: Rosiak, Grzegorz, et al.
Publicado: (2018)

Magnetic Nanomaterials as Contrast Agents for MRI
por: Caspani, Sofia, et al.
Publicado: (2020)

Revisiting morphine-augmented hepatobiliary imaging for diagnosing acute cholecystitis: the potential pitfall of high false positive rate
por: Hung, Bor-Tau, et al.
Publicado: (2014)

Prospective assessment of diagnostic efficacy and safety of Sonazoid(TM) and SonoVue(®) ultrasound contrast agents in patients with focal liver lesions
por: Lv, Ke, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_c56u8ccmp817flrron7i2ui44s